In our cohort, serum occludin levels were substantially elevated in AIS patients compared with carefully matched controls, with the highest levels observed among patients with large infarctions and severe neurological deficits, as reflected by admission NIHSS scores. The gene discussed is OCLN; the disease is androgen insensitivity syndrome.